PAX6 and melanoma: To characterize PAX6-negative cells, we performed double immunostaining on corneoscleral tissue sections using epithelial (keratin marker, Pan-CK), stromal (vimentin), and melanocytic (Melan-A and human melanoma black−45 (HMB−45)) markers.